Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability

Clinical trial NCT00986258 · TERMINATED

Trial details

NCT number: NCT00986258
Sponsor: Grünenthal GmbH
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Pain Chronic Pain Low Back Pain Neuropathic Pain Nociceptive Pain

Start date: 2009-10-30
Primary completion: 2010-12-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.